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http://dx.doi.org/10.1016/j.cels.2015.07.008In their highly publicized report on the
metagenomics of the NYC subway,
Afshinnekoo and colleagues display an
unfamiliarity with the genetics, micro-
biology, ecology, and epidemiology of
some of the organisms they claim to
have identified (Afshinnekoo et al., 2015).
Yersinia pestis, the cause of plague,
was first introduced into North America
circa 1900 through port cities along the
Pacific and Gulf coasts. The organism
spread into native rodent populations
and became established in the arid west-
ern United States. Although a few cases
occurred initially in New Orleans, LA,
and Pensacola, FL, none were observed
along the Atlantic coast, and the organism
quickly died out in all areas east of Texas
(Kugeler et al., 2015). Rodents, cats, and
humans are all exquisitely susceptible
to infection with Y. pestis, yet naturally
occurring infection has never been
observed within 1,000 miles of NYC.
A plague outbreak in NYC’s urban rat
population, let alone sporadic human
disease, would not go unnoticed. The
authors’ suggestion that humans and
plague bacilli have ‘‘interacted (and
potentially evolved)’’ in NYC is unfounded
and without scientific merit.
Genetically, Y. pestis is a monomorphic
pathogen (Achtman, 2012), displaying
limited sequence diversity between indi-
vidual strains (Vogler et al., 2011; Wagner
et al., 2014; Morelli et al., 2010). In
Figure 3B of their publication, the authors
highlight 12 nucleotide differences in the
NYC sequence reads as compared to
the murine toxin gene (ymt) present on
the Y. pestis pMT1 plasmid. The authors
provide this figure as evidence for identifi-
cation of Y. pestis, despite inconsistency
with publicly available sequence data for
Y. pestis. In fact, BLAST comparison of
ymt gene sequences in NCBI, from over
100 Y. pestis strains worldwide, demon-4 Cell Systems 1, July 29, 2015 ª2015 Elsevistrates the absence of nucleotide vari-
ability in this gene. Similarly, BLAST anal-
ysis of the entire Y. pestis pMT1 plasmid
(96 Kb) shows fewer nucleotide differ-
ences between the US strains (CO92,
A1122, CA88) in NCBI than identified by
the authors in the 550 bp segment they
analyzed (0.6% of the pMT1 plasmid). In
short, the reported nucleotide variability
is inconsistent with Y. pestis. Moreover,
the pMT1 coordinates in Figure 3B
(65,500–66,000) do not correspond to
the murine toxin coordinates (55,000–
56,000) shown in the samefigure, implying
the authors analyzed a locus other than
ymt. A more logical source of the NYC
sequences is from other bacteria within
the Enterobactericeae family, which are
known to encode plasmids with high
nucleotide similarity to pMT1 (GenBank:
CP010386, HG530657, CP003223) (Pren-
tice et al., 2001).
Similarly, the data presented do not
support the finding that Bacillus anthracis
DNA was present in the environmental
samples. As one would expect, the co-
authors reported that B. cereus was one
of the most commonly detected species.
B. thuringiensis and numerous other
Bacillus species are likely to be present
as well, and a large percentage of their
DNA would be 100% identical to the
B. anthracis genome. To claim that
B. anthracis was found in the NYC sub-
way, the co-authors must include the
B. anthracis-specific sequences that
were detected. This was not done in the
paper or in the supplemental information
posted online. Since a number of anthrax
cases did occur in NYC in 2001 (Holtz
et al., 2003) and 2006 (Nguyen et al.,
2010), and it is possible that animal skins
contaminated with B. anthracis spores
may continue to find their way into NYC,
this finding would be more scientifically
plausible than finding Y. pestis; however,er Inc.the data presented were not sufficient to
conclude this.
The co-authors also report that they
found antibiotic-resistant bacteria in the
NYC subway. While this finding is not a
surprise to public health and clinical ex-
perts, the published results did not sup-
port the claim. Remarkably, the authors
did not include detailed methods on how
bacteria were cultured, whether pure cul-
tures were obtained, use of controls, con-
centration of antibiotics, and confirmation
of bacterial or non-bacterial organisms.
Without clearly described methods and
procedures, including the controls that
were used, these results are meaningless.
Lastly, scientific investigations typically
devote some thought to limitations that
constrained their findings. Unfortunately,
the authors chose the more sensational
and less plausible interpretation of their
data, claiming that Y. pestis and
B. anthracis were found in the subway
and then speculating that ‘‘they likely
represent normal co-habitants of a shared
urban infrastructure [that] may even be
essential to maintaining such an environ-
ment and likely represent a normal,
‘‘healthy’’ metagenome profile of a city.’’
Based on flawed interpretations of the
findings reported in this paper, this last
statement is unfounded.
If the co-authors lacked microbiology
or public health background to ask them-
selves the right questions, then reviewers
with expertise in biological threat agents
were needed to point to these misunder-
standings prior to publication. This was
especially needed because, as the co-
authors claimed, their work was meant
to complement ‘‘monitoring to sustain
and secure [NYC] against acts of bioter-
rorism’’ and envisioned ‘‘as a first
step toward identifying potential bio-
threats’’ in the NYC subway. Unfortu-
nately, deeply flawed work that makes
Cell Systems
Lettersspeculative, sensationalist, and headline-
grabbing claims actually can detract
from the quiet, ongoing, science-based
efforts to secure critical infrastructure in
NYC and elsewhere.
REFERENCES
Achtman, M. (2012). Philos. Trans. R. Soc. Lond. B
Biol. Sci. 367, 860–867.
Afshinnekoo, E., Meydan, C., Chowdhury, S., Jar-
oudi, D., Boyer, C., Bernstein, N, Maritz, J.M.,
Reeves, D., Gandara, J., and Chhangawala, S.
(2015). Cell Systems 1, this issue, 6–7.Holtz, T.H., Ackelsberg, J., Kool, J.L., Rosselli, R.,
Marfin, A., Matte, T., Beatrice, S.T., Heller, M.B.,
Hewett, D., Moskin, L.C., et al. (2003). Emerg.
Infect. Dis. 9, 689–696.
Kugeler, K.J., Staples, J.E., Hinckley, A.F., Gage,
K.L., and Mead, P.S. (2015). Emerg. Infect. Dis.
21, 16–22.
Morelli, G., Song, Y., Mazzoni, C.J., Eppinger, M.,
Roumagnac, P., Wagner, D.M., Feldkamp, M., Ku-
secek, B., Vogler, A.J., Li, Y., et al. (2010). Nat.
Genet. 42, 1140–1143.
Nguyen, T.Q., Clark, N., Karpati, A., Goldberg, A.,
Paykin, A., Tucker, A., Baker, A., Almiroudis, A.,
Fine, A., Tsoi, B., et al.; 2006 NYC Anthrax WorkingCell SystGroup (2010). J. Public Health Manag. Pract. 16,
189–200.
Prentice, M.B., James, K.D., Parkhill, J., Baker,
S.G., Stevens, K., Simmonds, M.N., Mungall,
K.L., Churcher, C., Oyston, P.C., Titball, R.W.,
et al. (2001). J. Bacteriol. 183, 2586–2594.
Vogler, A.J., Chan, F., Wagner, D.M., Roumagnac,
P., Lee, J., Nera, R., Eppinger, M., Ravel, J., Raha-
lison, L., Rasoamanana, B.W., et al. (2011). PLoS
Negl. Trop. Dis. 5, e1319.
Wagner, D.M., Klunk, J., Harbeck, M., Devault, A.,
Waglechner, N., Sahl, J.W., Enk, J., Birdsell, D.N.,
Kuch, M., Lumibao, C., et al. (2014). Lancet Infect.
Dis. 14, 319–326.ems 1, July 29, 2015 ª2015 Elsevier Inc. 5
